Industry news, page-705

Also good to see psychedelics making a little bit of headway in the US congress -

'Two lawmakers in the U.S. House of Representatives have joined forces to create the Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus, a panel launched last week to advocate for research into psychedelic drugs. The caucus is co-chaired by California Democratic Representative Lou Correa and Representative Jack Bergman, a Republican from Michigan who is also a retired lieutenant general with the United States Marine Corps.

The new bipartisan caucus will advocate for research into psychedelics including psilocybin and MDMA, which have shown great promise as potential treatments for a range of mental health conditions including anxiety, treatment-resistant depression, addiction, and post-traumatic stress disorder.'

https://hightimes.com/psychedelics/house-lawmakers-launch-bipartisan-psychedelics-caucus/

'Preliminary research into the compounds has been so encouraging that the Food and Drug Administration has recently classified both MDMA- and psilocybin-assisted therapies as “breakthrough therapies,”'

https://hightimes.com/psychedelics/senators-cory-booker-rand-paul-introduce-psychedelics-bill/

Some other senators have introduced a bill - https://www.booker.senate.gov/imo/media/doc/breakthrough_therapies_act_final.pdf

'that would require the Drug Enforcement Administration (DEA) to reclassify breakthrough therapies such as the psychedelics psilocybin and MDMA. The bill, known as the Breakthrough Therapies Act, is designed to ease access to psychedelic drugs for patients and streamline further research into the compounds.'

Although it hasn't been passed into law yet, I think its great to see the topic at least being discussed and awareness raised.